Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaski

Showing results (931-940 of 1,021) with videos related to

Pageof 103
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|January 29, 2022
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyJuan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
Dementia (London, England)|October 31, 2018
Contributions of patient and citizen researchers to 'Am I the right way up?' study of balance in posterior cortical atrophy and typical Alzheimer's diseaseSebastian J Crutch, Keir Xx Yong, Amy Peters, et al.
European Heart Journal|February 5, 2025
Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive CardiologyHeribert Schunkert, Emanuele Di Angelantonio, Michael Inouye, et al.
Plos Computational Biology|November 3, 2011
Metabolic regulation in progression to autoimmune diabetesMarko Sysi-Aho, Andrey Ermolov, Peddinti V Gopalacharyulu, et al.
ESC Heart Failure|November 12, 2020
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registryFolkert W Asselbergs, Arjan Sammani, Perry Elliott, et al.
Circulation. Genomic and Precision Medicine|November 5, 2020
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European RegistryDor Lotan, Joel Salazar-Mendiguchía, Jens Mogensen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 24, 2019
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on StrokePatrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 7, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysisPaul M Haller, Niema Kazem, Stefan Agewall, et al.
Circulation Research|February 16, 2013
The Congenital Heart Disease Genetic Network Study: rationale, design, and early results, Bruce Gelb, Martina Brueckner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trialsHeinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
Pageof 103

Showing results (931-940 of 1,021) with videos related to

Sort By:
Pageof 103
European Heart Journal. Cardiovascular Pharmacotherapy|January 29, 2022
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyJuan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
Dementia (London, England)|October 31, 2018
Contributions of patient and citizen researchers to 'Am I the right way up?' study of balance in posterior cortical atrophy and typical Alzheimer's diseaseSebastian J Crutch, Keir Xx Yong, Amy Peters, et al.
European Heart Journal|February 5, 2025
Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive CardiologyHeribert Schunkert, Emanuele Di Angelantonio, Michael Inouye, et al.
Plos Computational Biology|November 3, 2011
Metabolic regulation in progression to autoimmune diabetesMarko Sysi-Aho, Andrey Ermolov, Peddinti V Gopalacharyulu, et al.
ESC Heart Failure|November 12, 2020
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registryFolkert W Asselbergs, Arjan Sammani, Perry Elliott, et al.
Circulation. Genomic and Precision Medicine|November 5, 2020
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European RegistryDor Lotan, Joel Salazar-Mendiguchía, Jens Mogensen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 24, 2019
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on StrokePatrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 7, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysisPaul M Haller, Niema Kazem, Stefan Agewall, et al.
Circulation Research|February 16, 2013
The Congenital Heart Disease Genetic Network Study: rationale, design, and early results, Bruce Gelb, Martina Brueckner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trialsHeinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
Pageof 103